Startup entity
Every one of those 1 sits in a single category, market-trends. Twist Bioscience is most often covered alongside ARK Invest, which appears in 1 of these 1 story. Each story carries 7 original sources on average, compared with 2.6 for the broader beat in this window.
Last mentioned: Mar 25, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, market-trends. Twist Bioscience is most often covered alongside ARK Invest, which appears in 1 of these 1 story. Each story carries 7 original sources on average, compared with 2.6 for the broader beat in this window. The 5 average consequence score is below the beat benchmark of 6.6 in the same window. Twist Bioscience appears in 1 tracked Startup story from March 25, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 46 Startup stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Twist Bioscience. Shared-story counts are live from our verified record — not editorial picks.
ARK Invest has executed a significant portfolio rebalancing, offloading shares of synthetic biology leader Twist Bioscience to increase its stake in Circle Internet Financial. This move signals a strategic shift toward digital dollar infrastructure as Circle gains momentum in the global stablecoin market.
Twist Bioscience is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
